Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00151-0/fulltext?dgcid=hubspot_email_conferencealerts_ias2023&utm_campaign=conferencealerts&utm_medium=email&_hsmi=267219605&_hsenc=p2ANqtz-90Rb0DbLFPiph9mi5VGhIEYcImU-srOitiGOJXI3qKbmpN21YtJOPbA9LWJ8fvuL06ii-JhdXjz7gQQ_a15QGoOO8s_A&utm_content=267219605&utm_source=hs_email